Legal & General Group Plc - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 102 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q1 2016$6,000
-62.5%
5,7270.0%0.00%
Q4 2015$16,000
-5.9%
5,7270.0%0.00%
Q3 2015$17,000
-48.5%
5,7270.0%0.00%
Q2 2015$33,000
-45.0%
5,7270.0%0.00%
Q1 2015$60,000
+11.1%
5,7270.0%0.00%
Q4 2014$54,000
+22.7%
5,7270.0%0.00%
Q3 2014$44,0005,7270.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders